An electrocatalytic dual molecularly imprinted polymer-based biosensor enables femtomolar detection of CD44 without antibodies
Analytica Chimica Acta · 2026-02 · 1385 · 345024
DOI: 10.1016/j.aca.2025.345024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2026-02. Verfasst von Ping Xia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University,…. Hauptthemen laut MEDLINE: Hyaluronan Receptors, Biosensing Techniques, Electrochemical Techniques, Molecularly Imprinted Polymers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The development of sandwich-type electrochemical immunosensors is critically constrained by the limited availability and high cost of well-matched antibody pairs. To address this, we present an antibody-free biosensing platform for the ultrasensitive detection of the cancer biomarker CD44, utilizing a pair of molecularly imprinted polymers (MIPs). A detection probe (P-MIP) featuring a sub-4-nm imprinted layer is synthesized on magnetic nanoparticles via metal affinity-oriented surface imprinting, leveraging Cu2+-histidine coordination for directional template immobilization. A complementary capture probe (E-MIP) is then formed on a miniaturized, 3D-printed electrode by in situ electropolymerization of a nanoscale polydopamine layer around the P-MIP-pre-captured CD44. This dual-orientation imprinting strategy effectively minimizes non-specific binding and enhanced target specificity. Crucially, the embedded Cu2+ centers serve both as structural anchors and intrinsic redox reporters, enabling label-free detection and enhancing conductivity. Integrating a 3D-printed microcell, the sensor achieves an exceptional detection limit of 0.31 pg mL-1 (13.4 fM) and a wide linear range (0.5 pg mL-1-50 ng mL-1) using merely 10 μL of sample. It demonstrates remarkable selectivity (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu, 610031, People's Republic of China.
- Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu, 610031, People's Republic of China; School of Physical and T…
- Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu, 610031, People's Republic of China. Electronic address: mas3…
- Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu, 610031, People's Republic of China. Electronic address: feng…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xia, P., Chen, C., Bai, R., Dong, W., Fu, Y., Zhang, C., Shan, L., & Feng, S. (2026). An electrocatalytic dual molecularly imprinted polymer-based biosensor enables femtomolar detection of CD44 without antibodies. Analytica Chimica Acta, 1385, 345024. https://doi.org/10.1016/j.aca.2025.345024
Vancouver
Xia P, Chen C, Bai R, Dong W, Fu Y, Zhang C, et al. An electrocatalytic dual molecularly imprinted polymer-based biosensor enables femtomolar detection of CD44 without antibodies. Analytica Chimica Acta. 2026;1385:345024. doi:10.1016/j.aca.2025.345024
BibTeX
@article{Xia2026,
author = {Xia, Ping and Chen, Cheng and Bai, Ruifang and Dong, Weige and Fu, Yuchun and Zhang, Chungu and Shan, Lianhai and Feng, Shun},
title = {An electrocatalytic dual molecularly imprinted polymer-based biosensor enables femtomolar detection of CD44 without antibodies},
journal = {Analytica Chimica Acta},
year = {2026},
volume = {1385},
pages = {345024},
doi = {10.1016/j.aca.2025.345024}
}
EUVIMED